Decatur Capital Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-18,928
Closed -$1.35M 50
2023
Q4
$1.35M Buy
18,928
+763
+4% +$53.1K 0.81% 42
2023
Q3
$1.26M Hold
18,165
0.91% 40
2023
Q2
$1.47M Sell
18,165
-191
-1% -$15.6K 1.01% 37
2023
Q1
$1.48M Sell
18,356
-2,785
-13% -$224K 1.12% 31
2022
Q4
$1.58M Sell
21,141
-14
-0.1% -$997 1.14% 34
2022
Q3
$1.36M Hold
21,155
1.03% 36
2022
Q2
$1.47M Buy
+21,155
New +$1.57M 1.08% 34

Other funds holding HOLX

Decatur Capital Management's HOLX Position: Q1 2024 in Review

Decatur Capital Management sold out of Hologic (HOLX) in Q1 2024, closing a stake of 18,928 shares — an estimated $1.35M sold.

Decatur Capital Management first reported a position in HOLX in Q2 2022 and held it in 7 quarters. The position peaked at $1.58M in Q4 2022. 705 funds tracked by Wall St. Rank hold HOLX as of Q1 2024.

  • Decatur Capital Management reported no remaining Hologic position as of Q1 2024 after selling out during the quarter.
  • Decatur Capital Management sold 18,928 Hologic shares in Q1 2024, an estimated $1.35M.
  • Decatur Capital Management first reported a position in Hologic in Q2 2022 and held it in 7 quarters.
  • Decatur Capital Management's Hologic position peaked at $1.58M in Q4 2022.
  • 705 funds tracked by Wall St. Rank held Hologic as of Q1 2024.

Based on Decatur Capital Management's 13F filing for Q1 2024, filed 15 May 2024.